SUMMARY A histochemical technique was used to identify the activity of the plasminogen activator (PA) in the vessel wall of veins. Antibodies against melanoma cell activator and urokinase (UK), both raised in goats, were mixed into the fibrin film. The PA activity was quenched by the antibodies against melanoma activator but remained unchanged when antibodies against UK, or an IgG preparation of normal goat serum, was mixed in the fibrin film. The results of this study show that the PA activity in the vein vessel wall is immunologically similar to or identical to the PA derived from melanoma cells which has previously been shown to cross-react with the tissue-like PA. No UK-like activity was present in the vessel wall.
The fibrinolytic system is activated by plasminogen activators localised in tissues, in blood and in different fluids of the human body. Two types of plasminogen activator (PA) have been recognised, blood/tissue-like and urokinase-like.
The blood vessels are considered to be the main source of blood and tissue PA.' 2 Using histochemical techniques, it has been demonstrated that PA is confined mainly to vasa vasorum and to the intima,'-3 from which the release of this activator occurs. [4] [5] [6] There are also inhibitors to the fibrinolytic system in the vessel wall,' which mainly inhibit urokinase.8
Urokinase (UK), the main activator in urine, is produced not only in the kidney and urinary outflow pathways,9 but is also present in carcinomas and tumour derived cell-lines'01" in normal uterine endometrium'2 and in various fetal organs. '3 Blood and tissue PA differ from UK in terms of immunological reaction, enzymatic activity and molecular weight.'3-'5 Blood PA can be increased by venous occlusion, physical exercise and various substances such as adrenaline, nicotinic acid, vasopressin and its synthetic analogue DDAVP.'6 Tissue PA is responsible for the fibrinolytic activity induced in human blood by the above mentioned stimuli.6 1 ' However, UK might be responsible for some of the spontaneous fibrinolytic activity in plasma.'8 '9 Accepted for publication 6 April 1983 We report here the quenching of PA activity in the vein vessel wall by monospecific antibodies against UK and PA of the blood/tissue-like type. '7 who demonstrated that the fibrinolytic activity of human blood induced by venous occlusion or DDAVP was quenched by antibodies to the melanoma plasminogen activator. UK-like material measured by radioimmunoassay, was not released by DDAVP, nor was the intrinsic fibrinolytic system of plasma affected. Furthermore, Astedt29 showed that there was no release of UKlike activity after venous occlusion. In the present study the PA activity of the vein vessel wall was exclusively tissue-like PA because it was completely quenched by anti-MA but not by anti-UK, nor by goat IgG. This is in agreement with the above mentioned studies that PA released from the vessel wall is of the tissue-like type.
Material and methods

DETERMINATION
Releasing the plasminogen activator content in the vein vessel wall into the blood stream is the most important function of the fibrinolytic defence system, and is one which has been shown to be defective in many patients suffering from recurrent thrombosis. 30 The present results bear this out and demonstrate that the plasminogen activator contained in the vessel wall is of the same type as that released by a variety of stimuli. 
